Chapter 367 next development (1)

All the leaders of American Airlines gathered in Seattle on this day. Zhang Yunfeng was not prepared to struggle any more. This time, only Seattle was chosen as the destination of his visit to the United States, so it was only those who rushed to Dongchen.

After the previous press conference, the media and the world are no longer focusing on the cooperation between Dongchen avionics and American Airlines, but on the next step of Dongchen electronics. In the current manufacturing industry, the one with the widest market prospect and the highest profit is the electronics industry, which has created too many top 500 enterprises in the world with high popularity . it covers a wide area. In the manufacturing industry, no industry can compare with it.

The electronics industry has always been led by Japanese and Korean enterprises, especially in the most developed countries such as Dongmu, Europe, North America, etc. there is still a certain gap in the electronics industry compared with Japanese enterprises, especially in the field of home appliances. At present, the Japanese brands and porcelain brands have the highest market share, followed by the cold and German brands. However, the Japanese brands account for half of the country, while the porcelain country The reason why the brand share is high is that the population of porcelain country accounts for a large proportion in the world. The market of porcelain country's home appliances in the export field is far less than the enterprises in the above countries.

If Dongchen is really ready to expand the business scope of Dongchen electronics in the next step, and can do as well as other products of Dongchen, then I'm afraid it will be worse for the economy of Japan and South Korea, and the scale of Dongchen will be leaped again.

At the time when the whole world was talking about this, Zhang Yunfeng signed the aeroengine sales contract with major airlines in the United States, and copied the model of cooperation with domestic airlines. In the United States, according to the level of airline passenger flow, he distributed the major airlines fairly.

Three days later, Zhang Yunfeng flew back to China, and the first batch of Dongchen's aeroengines were also transported to Seattle in the same day. Boeing also undertook the sales service in the United States for Dongchen, and was responsible for replacing Dongchen with the engine of the American Airlines' airliner.

Back home, Zhang Yunfeng took the lead in returning to the manor in the suburb. This time, he was going to hold a high-level meeting of Dongchen group to discuss the next development plan of Dongchen.

Dongchen Group CEO long Xiaoyue, Dongchen pharmaceutical director Yang Chenshan, Dongchen software director Huang Yong, Dongchen electronics CEO James from Oracle, and Dongchen automobile CEO hawkinson from general motors are all invited by Zhang Yunfeng. In addition, Zhang Yunran, Zhang Yunfeng's cousin, intends to let her come out of school and help her Help yourself to open up other businesses of Dongchen electronics, and Zhang Yunran agreed to Zhang Yunfeng's invitation after consideration.

For Zhang Yunfeng, the executive of every subsidiary of Dongchen is only the executor of his orders. In the development decision-making of Dongchen group at a large level, Zhang Yunfeng is absolutely arbitrary, and all the CEOs just try their best to carry out the orders given by Zhang Yunfeng. As the executors, Zhang Yunfeng doesn't need them to have a high creative mind, but They need to be as effective as soldiers.

Even if Zhang Yunran takes over the overall direction and strategy of Dongchen's new electronic business, Zhang Yunfeng has already formulated the overall policy in his mind. What he needs is the implementation of Zhang Yunran.

When all the people came to the manor, Zhang Yunfeng first invited them to have dinner in the manor. Then, all the people came to the largest conference room of the manor and sat around the conference table. Zhang Yunfeng took the lead in opening up.

, Therefore, I think it is necessary for Dongchen pharmaceutical to expand its business. "

Yang Chenshan, who has run a small pharmaceutical factory for half a life, has developed a lot of vision after more than a year of tempering in Dongchen pharmaceutical industry. He has long felt that the product line of Dongchen pharmaceutical industry is too single, which has basically lost the development space for the whole Dongchen pharmaceutical industry. When Zhang Yunfeng proposed to expand the business, Yang Chenshan could not help but say excitedly: "Zhang In my opinion, Dongchen pharmaceutical really needs to expand its product line. Now almost all large pharmaceutical companies are developing new drugs. The development of new drugs is not only of great social significance, but also of great economic value. I think it's time for us to establish our own R & D center. "

Zhang Yunfeng nodded and said, "the R & D center must be established, and it must be the best biological pharmaceutical R & D center in the world."

"Biological agents?" Yang Chenshan was a little confused and blurted out, "but the main product of Dongchen pharmaceutical is Chinese patent medicine."

Zhang Yunfeng smiled and said: "although there is a very high market for Chinese patent medicine, it still has a lot of deficiencies for major diseases, and the recognition of the international market is not high. Biological agents are the mainstream of high-end pharmaceutical market, such as cancer targeted drugs, which have a huge market prospect, a huge market influence and a huge profit space. This kind of drug is the East Chen pharmaceutical's next development direction. "

Said Zhang Yunfeng: "almost the world's top pharmaceutical companies have their own cutting-edge antibiotics. NACO in India and Roche in Switzerland have Troika technology, AstraZeneca in yangjili has Iressa and anastrozole, and ibital, a subsidiary of Merck group in Germany, all of which are targeted drugs for cancer, and the global sales volume is very good. However, this Although some drugs have good therapeutic effects for different types of cancer, they are far from being curable, which proves that the market prospect of specific drugs for malignant tumors is still very large. In my eyes, this is like a virgin land that has not been really reclaimed. "

However, Yang Chenshan was embarrassed to say, "president Zhang, we don't have the foundation for the development of this high-end biological medicine. You are clear about the situation of Dongchen pharmaceutical industry. Now we basically have no R & D department, only the production and sales department, and only the product of Qushi Zhenggu paste. If we start the research and development of high-end biological medicine now, I'm afraid that the period of effectiveness will be different Always long. "

Zhang Yunfeng waved his hand and said: "you don't need to worry about this. You just need to set up the research center of Biopharmaceutics first. The group will give you $100 million of special funds for the development of this project. In addition, the group will give you $200 million for the construction of high-end biopharmaceutical production lines, including separators, incubators, packaging, disinfection, etc You don't have to worry too much about how to use the complete hardware facilities of the series. You just need to build the hardware. "

Yang Chenshan nodded his head, which he had no opinion, nor could he have any opinion. Zhang Yunfeng's behavior style is very clear. Even if he has no bottom in his heart, don't doubt Zhang Yunfeng's action. If he asks so, he must have his own reasons.

From the very beginning, Dongchen pharmaceutical industry was a cash earning machine for the overall development of the later period. More than 80% of its existence was for Dongchen group to have sufficient funds to carry out other businesses quickly in the later period. Although Dongchen pharmaceutical industry has not been the focus of Zhang Yunfeng, Zhang Yunfeng understood that the pharmaceutical industry, and All industries are different, because they occupy not only the people's living needs, but also the people's living needs. At this point, the significance of medicine is far greater than any kind of commodity. Now, Zhang Yunfeng is going to catch up with Dongchen pharmaceutical again, build hardware facilities first, and then make full use of the knowledge in the small two and super learning system The development of high-end biological agents will be expanded until the development of Wallace, a special medicine for cancer, can be developed.

In the past, no real key point has been found in cancer treatment. Whether it's radiotherapy, chemotherapy, surgery or various adjuvant treatments, their ability is limited to controlling the spread of cancer cells, but they have no ability to completely kill cancer cells in the human body, whether it's cancer or AIDS, or those infectious bacteria that can be fatal when taken out. Their core key points It's the word "cell". The pathogenic cell is also a kind of organism. In general, they are no different from the cold bacteria. The only difference is that people have mastered how to kill the cold bacteria, but not how to kill those stubborn pathogenic cells.

In the pharmaceutics classification of the super learning system, all the diseases of human body are divided into two categories: one is the disease of human body itself, the other is the invasion of foreign diseases, cardiovascular and cerebrovascular diseases, Parkinson's disease, asthma, diabetes, all of which belong to the disease of human body itself, AIDS, rabies, malignant tumors, tuberculosis and various influenza The ultimate cure for the invasion of foreign pathogens is to completely kill them, which can only be achieved by antibiotics. How to develop antibiotics for different types of foreign pathogens has become the biggest problem for all pharmaceutical companies.

For Zhang Yunfeng, this is just a hardware problem. As long as the hardware meets the requirements, he can produce astonishing antibiotics to cure the global incurable diseases such as cancer and AIDS. If Dongchen group wants to raise its brand value and position to a peak, it can only be realized by Dongchen pharmaceutical industry At that time, Dongchen will not be an enterprise that brings the best products to consumers, but an enterprise that can save consumers' lives and keep consumers alive, such as a god like enterprise.

Yang Chenshan's request for Zhang Yunfeng is meaningless, and he is looking forward to Zhang Yunfeng's coming out with better medicine after he completes his request, so as to further the Dongchen pharmaceutical industry.

Then, Zhang Yunfeng said: "at present, the development of Dongchen automobile is stable. Our own products and the low-end products that we authorized the member enterprises of China cooperation alliance have achieved 70% coverage in the world. Even the whole world has developed a new emission standard because of Dongchen automobile. Now we have completely led the pace of the whole industry, and we do not need to do so in the future With a great development, Hodgson, you just need to maintain a stable development trend. I don't say much about this. In a few days, I will provide some new models to further improve and refine the product line of Dongchen automobile. "

The hawkinson dug by Zhang Yunfeng from general motors is not the cutting-edge talent in the world's automobile field, and Zhang Yunfeng only takes a look at his absolute executive power to bring him